Infant with deadly leukemia saved by drug for adult liver cancer

Doctors have successfully treated an infant with a rare childhood leukemia using a targeted therapy approved for adults with inoperable liver cancer and advanced kidney cancer. The decision to use the drug, sorafenib, was made after pathologists identified a unique mutation of two genes being fused together instead of on separate chromosomes.

From http://besthealthnews.com/2019/09/infant-with-deadly-leukemia-saved-by-drug-for-adult-liver-cancer/?utm_source=rss&utm_medium=rss&utm_campaign=infant-with-deadly-leukemia-saved-by-drug-for-adult-liver-cancer